AAAAAA

   
Results: 1-10 |
Results: 10
The role of language areas in motor control dysfunction in Parkinson's disease
Authors: Albani, G Kunig, G Soelch, CM Mauro, A Priano, L Martignoni, E Leenders, KL
Citation: G. Albani et al., The role of language areas in motor control dysfunction in Parkinson's disease, NEUROL SCI, 22(1), 2001, pp. 43-44
Changes in reward-induced brain activation in opiate addicts
Authors: Martin-Soelch, C Chevalley, AF Kunig, G Missimer, J Magyar, S Mino, A Schultz, W Leenders, KL
Citation: C. Martin-soelch et al., Changes in reward-induced brain activation in opiate addicts, EUR J NEURO, 14(8), 2001, pp. 1360-1368
Reward mechanisms in the brain and their role in dependence: evidence fromneurophysiological and neuroimaging studies
Authors: Martin-Soelch, C Leenders, KL Chevalley, AF Missimer, J Kunig, G Magyar, S Mino, A Schultz, W
Citation: C. Martin-soelch et al., Reward mechanisms in the brain and their role in dependence: evidence fromneurophysiological and neuroimaging studies, BRAIN RES R, 36(2-3), 2001, pp. 139-149
Changes in brain activation associated with reward processing in smokers and nonsmokers
Authors: Martin-Solch, C Magyar, S Kunig, G Missimer, J Schultz, W Leenders, KL
Citation: C. Martin-solch et al., Changes in brain activation associated with reward processing in smokers and nonsmokers, EXP BRAIN R, 139(3), 2001, pp. 278-286
Levodopa pharmacokinetic-pharmacodynamic modeling and 6-[F-18]levodopa positron emission tomography in patients with Parkinson's disease
Authors: Dietz, M Harder, S Graff, J Kunig, G Vontobel, P Leenders, KL Baas, H
Citation: M. Dietz et al., Levodopa pharmacokinetic-pharmacodynamic modeling and 6-[F-18]levodopa positron emission tomography in patients with Parkinson's disease, CLIN PHARM, 70(1), 2001, pp. 33-41
Reduced reward processing in the brains of Parkinsonian patients
Authors: Kunig, G Leenders, KL Martin-Solch, C Missimer, J Magyar, S Schultz, W
Citation: G. Kunig et al., Reduced reward processing in the brains of Parkinsonian patients, NEUROREPORT, 11(17), 2000, pp. 3681-3687
Benzodiazepine receptor binding in Huntington's disease: [C-11]flumazenil uptake measured using positron emission tomography
Authors: Kunig, G Leenders, KL Sanchez-Pernaute, R Antonini, A Vontobel, P Verhagen, A Gunther, I
Citation: G. Kunig et al., Benzodiazepine receptor binding in Huntington's disease: [C-11]flumazenil uptake measured using positron emission tomography, ANN NEUROL, 47(5), 2000, pp. 644-648
Bradykinesia in early Huntington's disease
Authors: Sanchez-Pernaute, R Kunig, G Alba, AD de Yebenes, JG Vontobel, P Leenders, KL
Citation: R. Sanchez-pernaute et al., Bradykinesia in early Huntington's disease, NEUROLOGY, 54(1), 2000, pp. 119-125
Pramipexole, a nonergot dopamine agonist, is effective against rest tremorin intermediate to advanced Parkinson's disease
Authors: Kunig, G Pogarell, O Moller, JC Delf, M Oertel, WH
Citation: G. Kunig et al., Pramipexole, a nonergot dopamine agonist, is effective against rest tremorin intermediate to advanced Parkinson's disease, CLIN NEUROP, 22(5), 1999, pp. 301-305
Facial pain in a case of cranial dystonia: a case report
Authors: Kunig, G Pogarell, O Oertel, WH
Citation: G. Kunig et al., Facial pain in a case of cranial dystonia: a case report, CEPHALALGIA, 18(10), 1998, pp. 709-711
Risultati: 1-10 |